Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hi-Clearance Inc. (1788:TWSE), powered by AI.
Hi-Clearance Inc. is currently trading at $131.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Hi-Clearance Inc. on Alpha Lenz.
View Hi-Clearance Inc.'s valuation metrics on Alpha Lenz.
“Hi-Clearance Inc.'s ROE is 12.2%. Explore profitability and growth together.”
Ask for details →Hi-Clearance Inc. is a medical device company specializing in the supply and distribution of equipment, consumables, and pharmaceutical products for the healthcare sector. Established in 1989 and headquartered in New Taipei City, Taiwan, the company serves diverse markets including renal care, cardiology, radiation treatment, dental care, oral surgery, and metabolic health. Its portfolio features dialyzers, dialysis machines, reverse osmosis (RO) water systems, interventional cardiovascular and radiological devices, dental implants and equipment, as well as blood glucose monitors, nutritional supplements, and related medications. Hi-Clearance also provides hemodialysis management services and operates as an original equipment manufacturer (OEM) for beverage ingredients. With a strategic goal of being a premier professional hemodialysis provider, Hi-Clearance plays a pivotal role in Taiwan’s healthcare infrastructure and supports hospital consumables logistics. The company’s activity in agency distribution expands its reach to global medical technology brands, making it a key channel provider in both clinical device supply and hospital operations throughout the region.
“Hi-Clearance Inc.'s ROE is 12.2%. Explore profitability and growth together.”
Ask for details →Hi-Clearance Inc. (ticker: 1788) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 131 with a P/E ratio of -x and P/B of -x.
ROE is 12.18% and operating margin is 9.85%. Annual revenue is $4.3B.